Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin-Reference-Cited by-同舟云学术

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin

Published:1991-07 Issue:1 Volume:91 Page:S25-S30
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Dujovne Carlos A.,Chremos A.N.,Pool James L.,Schnaper Harold,Bradford Reagan H.,Shear Charles L.,Higgins Jim,Downton Maria,Franklin Frank A.,Nash David T.,Gould A.Lawrence,Langendörfer Alexandra

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Lovastatin;Alberts;Cardiovasc Drug Rev,1989

2. Mevinolin stimulates receptor-medicated clearance of low-density lipoprotein from plasma in familial hypercholesterolemia heterozygotes;Bilheimer;Trans Assoc Am Phys,1983

3. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia;Grundy;N Engl J Med,1988

4. 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia;Hoeg;JAMA,1987

5. Lovastatin (Mevinolin) in the treatment of heterozygous familial hypercholesterolemia;Havel,1987

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New onset diabetes mellitus and cardiovascular outcomes according to statin intensity in patients after drug-eluting stent implantation in Asian patients;Scientific Reports;2023-09-25

2. Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants;Pharmacogenetics and Genomics;2023-07-23

3. A novel machine learning-based screening identifies statins as inhibitors of the calcium pump SERCA;Journal of Biological Chemistry;2023-05

4. Efficacy and Safety of Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts in Improving Lipid Profile of Patients with Mild-to-Moderate Hypercholesterolemia: A Self-Control Study;Nutraceuticals;2022-12-21

5. Safety of Statins and Nonstatins for Treatment of Dyslipidemia;Endocrinology and Metabolism Clinics of North America;2022-09